Fundraising Fox
/People
Sign in

Dominic Schmidt

Investor

General Partner at Advent Life Sciences

London

Writes $25K – $5M checks · typically $1M

Find your path to Dominic

496 people in our graph can introduce you to Dominic.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Silke R. Sperling to introduce you to Dominic

You →Silke · together at Max Planck Institute for Molecular Genetics (2006–2007) →Dominic

Ask Jamie Chen to introduce you to Dominic

You →Jamie · 8 people · together at Syncona Limited →Dominic

Ask Sam Okafor to introduce you to Dominic

You →Sam · 3 people · together at Advent Life Sciences →Dominic

Sign up to find every way you can get introduced to Dominic

  • Your email: the people you already email who know Dominic
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Dominic
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

About

Dominic Schmidt joined Advent Life Sciences in April 2022, with a background in biochemistry, genomics, molecular oncology, strategy consulting, and life science venture capital. He previously spent eight years as a Partner on the investment team at Syncona, a publicly listed healthcare investment company, where he helped found and grow several life science businesses. He holds a Diplom in Biochemistry from the Free University of Berlin and the Max Planck Institute for Molecular Genetics, and a PhD in Oncology from the University of Cambridge.

Invests in

BiotechLongevity

Experience

  1. Advent Life SciencesGeneral Partnercurrent2022 — presentLondon, England, United Kingdom
  2. Glycomine Inc.Non Executive Directorcurrent2024 — presentUnited States
  3. Beacon TherapeuticsBoard Observercurrent2024 — present
  4. Pheno Therapeutics LtdNon Executive Directorcurrent2024 — presentEdinburgh, Scotland, United Kingdom
  5. AviadoBioNon Executive Directorcurrent2022 — presentLondon, England, United Kingdom
  6. Amphista Therapeutics LimitedNon Executive Directorcurrent2022 — presentCambridge, England, United Kingdom
  7. Purespring TherapeuticsNon Executive Director2020 — 2022
  8. Forcefield TherapeuticsNon Executive Director2020 — 2022
  9. Anaveon AGNon Executive Director2019 — 2022Switzerland
  10. Syncona LimitedPartner2016 — 2022London, United Kingdom
  11. Syncona LimitedPartner2014 — 2016London, United Kingdom
  12. GYROSCOPE Therapeutics LtdNon Executive Director and Board Observer2019 — 2022
  13. Orbit Biomedical, Inc.Non Executive Director2018 — 2021London / Philadelphia
  14. Freeline Therapeutics LimitedBoard Observer2015 — 2020London
  15. L.E.K. ConsultingAssociate2012 — 2014
  16. Cancer Research UKDoctoral Student2007 — 2011
  17. Max Planck Institute for Molecular GeneticsMaster Student and Research Assistant2006 — 2007

Skills & more

Lifesciences27Genomics14Due Diligence19Biotechnology12Private Equity6Statistics5Biochemistry7Oncology2Management Consulting5Molecular Biology9Valuation5Cell Culture5
+10 moreStrategyBioinformaticsBusiness StrategyCell BiologyGeneticsData AnalysisLife SciencesStrategy ConsultingVenture CapitalFinancial Modeling

Languages English · German

From Dominic's professional profile.

Investments

Board seats

Amphista TherapeuticsAviadoBioBeacon TherapeuticsGlycomineGyroscope TherapeuticsOrbit BiomedicalPheno Therapeutics

Sources: the firm's website · curated public sources.

Colleagues at Advent Life Sciences

Alain Huriez
Venture Partner at Advent Life Sciences
Alan Walts
Venture Partner at Advent Life Sciences
Andrea Beesley
Team Assistant at Advent Life Sciences
Bonita Theara
Executive Assistant at Advent Life Sciences
Dale Pfost
Executive Officer at Advent Life Sciences
Don Drakeman
Distinguished Research Professor, biotech entrepreneur, and venture partner
Fraser Murray
Head of Scientific Evaluation at Advent Life Sciences
Gail Jermyn
Investor Relations Partner at Advent Life Sciences

Network4

Alain Huriez
Venture Partner at Advent Life Sciences
Alan Walts
Venture Partner at Advent Life Sciences
Don Drakeman
Distinguished Research Professor, biotech entrepreneur, and venture partner
Kaasim Mahmood
General Partner at Advent Life Sciences

Investors connected to Dominic in public investor directories — a warm-intro map.

Frequently asked questions

Who is Dominic Schmidt?
Dominic Schmidt joined Advent Life Sciences in April 2022, with a background in biochemistry, genomics, molecular oncology, strategy consulting, and life science venture capital. He previously spent eight years as a Partner on the investment team at Syncona, a publicly listed healthcare investment company, where he helped found and grow several life science businesses. He holds a Diplom in Biochemistry from the Free University of Berlin and the Max Planck Institute for Molecular Genetics, and a PhD in Oncology from the University of Cambridge.
Where does Dominic Schmidt work?
Dominic Schmidt is General Partner at Advent Life Sciences.
What does Dominic Schmidt invest in?
Dominic Schmidt invests in Biotech, Longevity.
What check size does Dominic Schmidt write?
Dominic Schmidt typically writes checks of $25K – $5M.
What boards does Dominic Schmidt sit on?
Dominic Schmidt holds tracked board seats at Amphista Therapeutics, AviadoBio, Beacon Therapeutics, Glycomine, Gyroscope Therapeutics, Orbit Biomedical, Pheno Therapeutics.
What companies has Dominic Schmidt invested in?
Investments tracked here include Glycomine, Purespring.
Where did Dominic Schmidt go to school?
Dominic Schmidt studied at University of Cambridge (Doctor of Philosophy (Ph.D.), Oncology); Freie Universität Berlin (German Diplom Degree / M.Sc., Biochemistry).

Same school

Shared employers